Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

SAN DIEGO - Boundless Bio (NASDAQ:BOLD) reported a fourth quarter loss of -$0.58 per share, beating analyst estimates of -$1.16 per share, as the clinical-stage oncology company opened enrollment for ...

Here’s a roundup of the most significant insider trading activity disclosed on Thursday for US stocks, featuring major purchases and sales by company executives and directors. AdaptHealth Corp saw the ...

This study presents valuable findings that could potentially allow a deeper understanding of the immunopathogenesis underlying influenza infection in aged mice. The results are based on solid evidence ...

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, ...

Future endeavors took center stage at the March 9 McCook School Board meeting, as board members discussed upcoming trips, facility repairs, school improvement goals and potential legislation. With the ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...

Making money online with video isn't only for people with fancy gear or editing skills. With a Free AI Video Generator like InVideo AI, you can go from an ...

In 2016, Elizabeth Thomas began secretly meeting her married teacher. A year later, they vanished together ...

For more details, visit Progress Software invites applications for the 2026 Progress Akanksha Scholarship for Women in STEM in India. Eligibility: Women who are Indian citizens enrolled in the first ...

FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical see ...